Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Current Topics in Medicinal Chemistry|July 8, 2017
Can Untargeted Metabolomics Be Utilized in Drug Discovery/Development?Gary W Caldwell, Gregory C LeoAnalytical Chemistry|April 26, 2003
Application of flow NMR to an open-access pharmaceutical environmentGregory C Leo, Aaron Krikava, Gary W CaldwellDrug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2006
Biotransformation of geldanamycin and 17-allylamino-17-demethoxygeldanamycin by human liver microsomes: reductive versus oxidative metabolism and implicationsWensheng Lang, Gary W Caldwell, Jian Li, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 22, 2005
Bioactivation of 4-methylphenol (p-cresol) via cytochrome P450-mediated aromatic oxidation in human liver microsomesZhengyin Yan, H Marlon Zhong, Noureddine Maher, et al.Expert Opinion on Drug Discovery|May 9, 2015
In silico tools used for compound selection during target-based drug discovery and developmentGary W CaldwellAnalytical Biochemistry|March 16, 2005
The application of nuclear magnetic resonance-based metabonomics to the dominant-submissive rat behavioral modelGregory C Leo, Gary W Caldwell, Jeffrey Crooke, et al.Journal of Pharmaceutical and Biomedical Analysis|January 3, 2006
Distribution and metabolism of the antipsychotic agent mazapertine succinate in ratsGary W Caldwell, Wu-Nan Wu, Linda A McKown, et al.Current Topics in Medicinal Chemistry|July 8, 2017
An In Vivo Rat α-D-glucose Stable Isotope Homeostasis Drug Discovery Screen: A Targeted Metabolomics ApproachGary W Caldwell, Wensheng LangAnalytical Chemistry|December 2, 2004
Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signatureZhengyin Yan, Gary W CaldwellCurrent Opinion in Drug Discovery & Development|February 1, 2006
Screening for reactive intermediates and toxicity assessment in drug discoveryGary W Caldwell, Zhengyin YanPageof 5